PURPOSE: Although preserved glucose metabolism is considered to be a marker of myocardial viability in the chronic stage, it has not been fully elucidated whether this is also true with regard to reperfused acute myocardial infarction (AMI). The aim of this study was to compare the diagnostic performance of(99m)Tc-tetrofosmin SPECT and(18)F-fluorodeoxyglucose (FDG) PET for the prediction of functional recovery in reperfused AMI. METHODS: The study population comprised 28 patients. Both tetrofosmin SPECT and FDG PET were performed in all 28 patients at ca. 2 weeks and in 23 at 6 months. The tetrofosmin and FDG findings in infarct-related segments were compared with the regional wall motion score assessed by left ventriculography over 6 months to determine the predictive value for functional recovery. RESULTS: Of 120 infarct-related segments, 83 had preserved flow (tetrofosmin uptake >/=50%) and 81 had preserved glucose metabolism (FDG uptake >/=40%). The sensitivity and specificity of tetrofosmin SPECT for the prediction of functional recovery tended to be superior to those of FDG PET (90.0% and 72.5% vs 85.0% and 67.5%, respectively). Thirteen segments with preserved flow and decreased glucose metabolism demonstrated marked recovery of contractile function from 2.5+/-1.0 to 1.4+/-1.4 (p<0.01), with restoration of glucose metabolism at 6 months. In contrast, 11 segments with decreased flow and preserved glucose metabolism demonstrated incomplete functional improvement from 3.0+/-0.8 to 2.2+/-1.2. CONCLUSION: In the subacute phase, preserved myocardial blood flow is more reliable than glucose metabolism in predicting functional recovery in reperfused myocardium.
PURPOSE: Although preserved glucose metabolism is considered to be a marker of myocardial viability in the chronic stage, it has not been fully elucidated whether this is also true with regard to reperfused acute myocardial infarction (AMI). The aim of this study was to compare the diagnostic performance of(99m)Tc-tetrofosmin SPECT and(18)F-fluorodeoxyglucose (FDG) PET for the prediction of functional recovery in reperfused AMI. METHODS: The study population comprised 28 patients. Both tetrofosmin SPECT and FDG PET were performed in all 28 patients at ca. 2 weeks and in 23 at 6 months. The tetrofosmin and FDG findings in infarct-related segments were compared with the regional wall motion score assessed by left ventriculography over 6 months to determine the predictive value for functional recovery. RESULTS: Of 120 infarct-related segments, 83 had preserved flow (tetrofosmin uptake >/=50%) and 81 had preserved glucose metabolism (FDG uptake >/=40%). The sensitivity and specificity of tetrofosmin SPECT for the prediction of functional recovery tended to be superior to those of FDG PET (90.0% and 72.5% vs 85.0% and 67.5%, respectively). Thirteen segments with preserved flow and decreased glucose metabolism demonstrated marked recovery of contractile function from 2.5+/-1.0 to 1.4+/-1.4 (p<0.01), with restoration of glucose metabolism at 6 months. In contrast, 11 segments with decreased flow and preserved glucose metabolism demonstrated incomplete functional improvement from 3.0+/-0.8 to 2.2+/-1.2. CONCLUSION: In the subacute phase, preserved myocardial blood flow is more reliable than glucose metabolism in predicting functional recovery in reperfused myocardium.
Authors: J vom Dahl; C Altehoefer; F H Sheehan; P Buechin; R Uebis; B J Messmer; U Buell; P Hanrath Journal: J Am Coll Cardiol Date: 1996-10 Impact factor: 24.094
Authors: Gregg W Stone; Michael A Peterson; Alexandra J Lansky; George Dangas; Roxana Mehran; Martin B Leon Journal: J Am Coll Cardiol Date: 2002-02-20 Impact factor: 24.094
Authors: L Sebree; J A Bianco; R Subramanian; M A Wilson; D Swanson; J Hegge; J Tschudy; R Pyzalski Journal: J Mol Cell Cardiol Date: 1991-05 Impact factor: 5.000
Authors: W Wijns; J A Melin; N Leners; A Ferrant; A Keyeux; J Rahier; M Cogneau; C Michel; A Bol; A Robert Journal: J Nucl Med Date: 1988-11 Impact factor: 10.057
Authors: M Schwaiger; R Brunken; M Grover-McKay; J Krivokapich; J Child; J H Tillisch; M E Phelps; H R Schelbert Journal: J Am Coll Cardiol Date: 1986-10 Impact factor: 24.094
Authors: P Perrone-Filardi; S L Bacharach; V Dilsizian; J A Marin-Neto; S Maurea; J A Arrighi; R O Bonow Journal: J Am Coll Cardiol Date: 1994-03-01 Impact factor: 24.094
Authors: Heerajnarain Bulluck; Steven K White; Georg M Fröhlich; Steven G Casson; Celia O'Meara; Ayla Newton; Jennifer Nicholas; Peter Weale; Simon M Y Wan; Alex Sirker; James C Moon; Derek M Yellon; Ashley Groves; Leon Menezes; Derek J Hausenloy Journal: Circ Cardiovasc Imaging Date: 2016-03 Impact factor: 7.792